Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPIA | P62937 | 20/20 | 0.81 |
| ▸ | SLCO1B1 | Q9Y6L6 | 4/20 | 0.81 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.81 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.81 |
| ▸ | ABCC2 | Q92887 | 2/20 | 0.81 |
| ▸ | SLCO1B3 | Q9NPD5 | 2/20 | 0.81 |
| ▸ | PPIB | P23284 | 15/20 | 0.80 |
| ▸ | MEN1 | O00255 | 1/20 | 0.78 |
| ▸ | NPC1 | O15118 | 1/20 | 0.78 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.78 |
| ▸ | GMNN | O75496 | 1/20 | 0.78 |
| ▸ | USP2 | O75604 | 1/20 | 0.78 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 0.78 |
| ▸ | LMNA | P02545 | 1/20 | 0.78 |
| ▸ | POLB | P06746 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.78 |
| ▸ | MAPT | P10636 | 1/20 | 0.78 |
| ▸ | RARB | P10826 | 1/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.78 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19861134 | 0.99 | PPIA (0.81) | PPIASLCO1B1ABCB11ABCB1ABCC2 | |
| SCHEMBL15183408 | 0.99 | PPIA (0.81) | PPIASLCO1B1ABCB11ABCB1ABCC2 | |
| SCHEMBL16657047 | 0.96 | PPIA (0.80) | PPIASLCO1B1ABCB11ABCB1ABCC2 | |
| SCHEMBL15183419 | 0.94 | PPIA (0.88) | PPIASLCO1B1ABCB11ABCB1ABCC2 | |
| SCHEMBL19861247 | 0.94 | PPIA (0.88) | PPIASLCO1B1ABCB11ABCB1ABCC2 | |
| SCHEMBL15183415 | 0.94 | PPIA (0.88) | PPIASLCO1B1ABCB11ABCB1ABCC2 | |
| SCHEMBL19861293 | 0.94 | PPIA (0.88) | PPIASLCO1B1ABCB11ABCB1ABCC2 | |
| SCHEMBL16657075 | 0.94 | PPIA (0.83) | PPIASLCO1B1ABCB11ABCB1ABCC2 | |
| SCHEMBL15183897 | 0.94 | PPIA (0.83) | PPIASLCO1B1ABCB11ABCB1ABCC2 | |
| SCHEMBL15183411 | 0.93 | PPIA (0.82) | PPIASLCO1B1ABCB11ABCB1ABCC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150111815-A1 | NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS | S & T GLOBAL INC (US) | 2015-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150111815-A1 | NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS | HAVCR2, TSLP, HLA-DRB1 | PPIA 682/4885SLCO1B1 697/4885ABCB11 306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.